Motley Fool Premium
  1. Stocks
    2. /
  2. AstraZeneca Plc (LSE: AZN)
    3. /

LSE:AZN (AstraZeneca Plc)

About AZN

AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
Financial Market Data copyright © 2026 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

AstraZeneca Plc (LSE: AZN) Latest News

Investing Articles

Why AstraZeneca plc Should Beat GlaxoSmithKline plc In 2015

| Alan Oscroft

AstraZeneca plc (LON: AZN) has come from behind and is overtaking GlaxoSmithKline plc (LON:GSK).

Read more »

Investing Articles

Which Company Suits Your Portfolio: AstraZeneca plc Or GlaxoSmithKline plc ?

| Rupert Hargreaves

Which is the better pick for your portfolio, AstraZeneca plc (LON:AZN), or GlaxoSmithKline plc (LON: GSK)?

Read more »

Investing Articles

As Deadline Passes, Will AstraZeneca plc Attract A New Bid From Pfizer Inc?

| Roland Head

Roland Head asks whether AstraZeneca plc (LON:AZN) still holds the same attraction for Pfizer Inc.

Read more »

Investing Articles

Is It Too Late To Buy November’s Winners, AstraZeneca plc And Vodafone Group plc?

| Harvey Jones

AstraZeneca plc (LON: AZN) and Vodafone Group plc (LON: VOD) have been on a winning streak, Harvey Jones asks whether…

Read more »

Investing Articles

2 Numbers That Could Make AstraZeneca plc A Terrific Turnaround Play

| Royston Wild

Royston Wild explains why AstraZeneca plc (LON: AZN) could prove a classic contrarian winner.

Read more »

Investing Articles

Neil Woodford Praises AstraZeneca plc’s Prospects

| Rupert Hargreaves

Woodford is excited about AstraZeneca plc's (LON: AZN) future prospects.

Read more »

Investing Articles

AstraZeneca plc: Why $4.20 Is The Magic Number

| Rupert Hargreaves

AstraZeneca plc's (LON: AZN) management will be keeping a keen eye on the company's earnings.

Read more »

Investing Articles

Forget About 2015: Why AstraZeneca plc Remains A Spectacular Long-Term Pick

| Royston Wild

Royston Wild explains why AstraZeneca plc (LON: AZN) may prove to be a red-hot growth selection.

Read more »

Investing Articles

At What Price Would AstraZeneca plc Be A Bargain Buy?

| G A Chester

G A Chester explains his bargain-buy price for AstraZeneca plc (LON:AZN).

Read more »

Investing Articles

My Top 3 Pharmaceutical Stocks For 2015: GlaxoSmithKline plc, AstraZeneca plc And BTG plc

| Peter Stephens

GlaxoSmithKline plc (LON: GSK), AstraZeneca plc (LON: AZN) and BTG plc (LON: BTG) could have a great 2015

Read more »

Investing Articles

AstraZeneca plc And GlaxoSmithKline plc Are Strong Buys, But For Very Different Reasons

| Harvey Jones

AstraZeneca plc (LON: AZN) and GlaxoSmithKline plc (LON: GSK) have their differences, but there is strength in diversity, says Harvey…

Read more »

Investing Articles

Can AstraZeneca plc Beat The FTSE 100 In 2015?

| Peter Stephens

Should you buy shares in AstraZeneca plc (LON: AZN) in expectation of FTSE 100-beating performance next year?

Read more »